17. RESTATEMENT (Details 1) - USD ($)	3 Months Ended								12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2014
Research and development expenses									$ 17,445,382	$ 19,191,750	$ 15,266,189
Total operating expenses	$ 6,738,472	$ 6,036,123	$ 5,829,779	$ 5,327,509	$ 7,797,084	$ 8,114,099	$ 7,480,363	$ 9,655,979	23,931,883	33,047,525	25,931,747
Operating loss									(23,646,828)	(32,390,148)	(25,667,714)
Interest income (expense), net									(1,879,390)	(1,964,221)	(1,933,732)
Net loss									$ (11,512,492)	$ (34,692,210)	$ (27,352,679)
Net loss per common share, basic and diluted	$ (0.21)	$ (0.78)	$ (1.87)	$ 0.53					$ (2.37)	$ (10.51)
Net loss per share, basic					$ (2.54)	$ (1.32)	$ (4.14)	$ (2.68)	(2.37)	(10.51)	$ (12.10)
Net loss per share, diluted					$ (2.54)	$ (1.62)	$ (4.14)	$ (3.42)	$ (2.37)	$ (10.51)	$ (12.21)
Previously Reported
Research and development expenses									$ 19,351,779	$ 21,098,147	$ 17,172,587
Total operating expenses									25,838,280	34,953,922	27,838,145
Operating loss									(25,553,225)	(34,296,545)	(27,574,112)
Interest income (expense), net									73,001	(40,260)	(40,920)
Net loss									$ (11,466,498)	$ (34,674,646)	$ (27,366,265)
Net loss per common share, basic and diluted									$ (2.36)	$ (10.51)
Net loss per share, basic											$ (12.11)
Net loss per share, diluted											$ (12.22)
Adjustment
Research and development expenses									$ (1,906,397)	$ (1,906,397)	$ (1,906,398)
Total operating expenses									(1,906,397)	(1,906,397)	(1,906,398)
Operating loss									1,906,397	1,906,397	1,906,398
Interest income (expense), net									(1,952,391)	(1,923,961)	(1,892,812)
Net loss									$ (45,994)	$ (17,564)	$ 13,586